Conference call today at 9:00 am ETQ4 2025 revenues of $112M, +46% vs. Q4 2024 Furoscix® Q4 2025 net sales of $23M, +91% vs.

Many of us take medications to relieve pain, fight infections, or manage chronic conditions. While these therapies offer important health benefits, it's worth understanding a lesser-known ...